Aug 6, 2020 | Securities Class Action Archive
Purchasers Or Sellers Of May 2020 Light Sweet Crude Oil Futures Contracts (WTI) Traded On NYMEX Between April 20, 2020 and April 21, 2020 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential antitrust claims on behalf of purchasers or sellers of May 2020 WTI Crude Oil Futures Contracts traded on the NYMEX between April 20, 2020 and April 21, 2020.
Specifically, the investigation focuses on whether Vega Capital London Ltd. traders colluded to put downward pressure on oil futures contract prices to reap a huge, one-day profit windfall when the oil futures markets collapsed.
Purchasers or sellers of May 2020 Light Sweet Crude Oil Futures Contracts (WTI) traded on the NYMEX between April 20, 2020 and April 21, 2020 are encouraged to contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to discuss the antitrust investigation or potential legal claims.
Jul 30, 2020 | Securities Class Action Archive
Velocity Financial Investors With Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Velocity Financial, Inc. (“Velocity” or the “Company”) (NYSE: VEL) to determine whether the Company engaged in securities fraud or other unlawful business practices.
Velocity investors who purchased, or otherwise acquired, the Company’s common stock in connection with its January 2020 Initial Public Offering (“IPO”) and suffered losses greater than $50,000 are encouraged to complete Kehoe Law Firm’s Securities Class Action Questionnaire or contact Kevin Cauley, Director, Business Development, (215) 792-6676, Ext. 802, [email protected], [email protected], [email protected], to discuss the securities investigation or potential legal claims.
Velocity investors should be aware that a class action lawsuit has been filed against Velocity on behalf of investors who purchased or acquired Velocity common stock in connection with the Company’s IPO.
According to the class action complaint, the Offering Materials issued in connection with Velocity’s IPO ” . . . were negligently prepared and, as a result, contained untrue statements of material fact, omitted material facts necessary to make the statements contained therein not misleading, and failed to make necessary disclosures required under the rules and regulations governing their preparation.”
Velocity investors should be aware that the value of Velocity’s common stock has declined since the IPO. In fact, during intraday trading on July 30, 2020, the Company’s stock was trading below $4.00 per share.
Jul 27, 2020 | Securities Class Action Archive
Vaxart Investors With Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAQ: VXRT) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On June 26, 2020, Vaxart announced that “. . . its oral COVID-19 vaccine has been selected to participate in a non-human primate (NHP) challenge study, organized and funded by Operation Warp Speed, a new national program aiming to provide substantial quantities of safe, effective vaccine for Americans by January 2021,” as well as that Vaxart is “. . . one of the few companies selected by Operation Warp Speed, and that ours is the only oral vaccine being evaluated.”
On July 25, 2020, a New York Times article, “Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine,” described how Vaxart’s “[c]ompany insiders, who weeks earlier had received stock options worth a few million dollars, saw the value of those awards increase sixfold. And a hedge fund that partly controlled the company walked away with more than $200 million in instant profits.”
According to The New York Times, “[s]ome officials at the Department of Health and Human Services have grown concerned about whether companies including Vaxart are trying to inflate their stock prices by exaggerating their roles in Warp Speed, a senior Trump administration official said. The department has relayed those concerns to the Securities and Exchange Commission, said the official, who spoke on the condition of anonymity.”
On this news, Vaxart’s share price dropped significantly on July 27, 2020, closing at $11.16 per share.
Vaxart investors who purchased, or otherwise acquired, the Company’s common stock and suffered losses greater than $50,000 are encouraged to complete Kehoe Law Firm’s Securities Class Action Questionnaire or contact Kevin Cauley, Director, Business Development, (215) 792-6676, Ext. 802, [email protected], [email protected], to discuss the securities investigation or potential legal claims.
Jul 23, 2020 | Securities Class Action Archive
Acer Therapeutics Investors Who Have Held Their Stock Continuously Since At Least September 25, 2017 Are Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential breaches of fiduciary duty claims involving certain officers and/or directors of Acer Therapeutics, Inc. (“Acer” or the “Company”) (NASDAQ: ACER).
The investigation concerns, among other things, whether certain Acer officers and/or directors made materially false and misleading statements and/or failed to disclose material information regarding, among other things, the Company’s business, operational, and compliance policies and whether Acer lacked sufficient data to support filing EDSIVO’s (celiprolol) New Drug Application (“NDA”) with the FDA for the treatment of Ehlers-Danlos Syndrome (“vEDS”).
Investors who have owned Acer stock continuously since at least September 25, 2017 are encouraged to contact Kehoe Law Firm, P.C., Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], [email protected], to discuss the investigation or potential legal claims.
Jul 20, 2020 | Securities Class Action Archive
Kehoe Law Firm, P.C. is investigating potential breaches of fiduciary duty claims involving certain officers and/or directors of VMware, Inc. (“VMware” or the “Company”) (NYSE: VMW).
The investigation concerns, among other things, whether the Company’s officers and/or directors misled investors and breached their fiduciary duties by issuing materially false and/or misleading statements regarding, among other things, VMware’s business, operations, and prospects.
VMware investors who have owned their stock continuously since at least March 30, 2019 are encouraged to contact Kehoe Law Firm, P.C., Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], [email protected], to discuss the investigation or potential legal claims.
Jul 16, 2020 | Securities Class Action Archive
Deutsche Bank Investors Who Purchased The Company’s Securities Between November 7, 2017 and July 6, 2020, Both Dates Inclusive, And Suffered Losses Greater Than $500,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating securities claims on behalf of investors of Deutsche Bank Aktiengesellschaft (“Deutsche Bank” or the “Company”) (NYSE: DB) to determine whether Deutsche Bank may have issued materially misleading business information to investors.
Deutsche Bank investors who purchased, or otherwise acquired, the Company’s securities between November 7, 2017 and July 6, 2020, both dates inclusive (the “Class Period”) and suffered losses greater than $500,000 are encouraged to complete Kehoe Law Firm’s Securities Class Action Questionnaire or contact Kevin Cauley, Director, Business Development, (215) 792-6676, Ext. 802, [email protected], [email protected], to discuss the securities investigation or potential legal claims.
A class action lawsuit has been filed against Deutsche Bank and certain company officers seeking to recover damages caused by Defendants’ alleged violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.
According to the class action complaint, throughout the Class Period, Defendants, allegedly, made materially false and misleading statements regarding the Company’s business. Defendants, allegedly, made false and/or misleading statements and/or failed to disclose that: (i) Deutsche Bank had failed to remediate deficiencies related to AML, its disclosure controls, procedures, and internal control over financial reporting, and its U.S. operations’ troubled condition; (ii) as a result, Deutsche Bank failed to properly monitor customers that Deutsche Bank itself deemed to be high risk, including, among others, the convicted sex offender Jeffrey Epstein and two correspondent banks, Danske Estonia and FBME Bank, both of which were the subjects of prior scandals involving financial misconduct; (iii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on Deutsche Bank’s financial results and reputation; and (iv) as a result, Deutsche Bank’s public statements were materially false and misleading at all relevant times.
